UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2615-2623

2015

Volltextzugriff (PDF)

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

Gynecologic oncology, 2016-07, Vol.142 (1), p.89-94

2016

Volltextzugriff (PDF)

Decomposing inversion sets of permutations and applications to faces of the Littlewood–Richardson cone

Journal of algebraic combinatorics, 2017-06, Vol.45 (4), p.1173-1216

2017

Volltextzugriff (PDF)

Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn?

Journal of chemotherapy (Florence), 2004-11, Vol.16 Suppl 4, p.44

Dewji, M R

2004

Volltextzugriff (PDF)

Bond strength of Bis-GMA and glass ionomer pit and fissure sealants using cyclic fatigue

European journal of oral sciences, 1998-02, Vol.106 (1), p.594-599

1998

Volltextzugriff (PDF)

Back to basics: tackling the challenges to bedside teaching

Advances in medical education and practice, 2015-01, Vol.6 (default), p.17-18

2015

Volltextzugriff (PDF)

First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8013-8013

2006

Volltextzugriff (PDF)

A phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM)

Melanoma research, 2006-09, Vol.16 (Supplement 1), p.S82

2006

Volltextzugriff (PDF)

196 A phase III randomised study of amifostine vs G-CSF to prevent the myelotoxicity of carboplatin chemotherapy in non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.52-52

1997

Volltextzugriff (PDF)

Docetaxel (D) in combination with amifostine (A) in metastatic breast cancer (MBC): A feasibility and pharmacoklnetlc study of the EORTC-investigational drug branch for breast cancer (IDBBC)

European journal of cancer (1990), 1997-09, Vol.33, p.S159-S159

1997

Volltextzugriff (PDF)

Phase I study on 4-weekly 6 hour infusion of BMY-25067 in patients (PTS) with solid tumors

European journal of cancer (1990), 1993, Vol.29, p.S119-S119

1993

Volltextzugriff (PDF)

Phase I study of the mitomycin C analogue BMY 25067

European journal of cancer (1990), 1993, Vol.29, p.S120-S120

1993

Volltextzugriff (PDF)

Validation of gamma-ray detection techniques for safeguards monitoring at natural uranium conversion facilities

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2016-07, Vol.823 (C), p.135-148

2016

Volltextzugriff (PDF)

G446(P) A systematic review evaluating the methodological quality of infant formula trials

Archives of disease in childhood, 2020-10, Vol.105 (Suppl 1), p.A161-A161

2020

Volltextzugriff (PDF)

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation

Cancer chemotherapy and pharmacology, 2013-05, Vol.71 (5), p.1191-1199

2013

Volltextzugriff (PDF)

Effects of 12 Weeks of At-Home, Application-Based Exercise on Health Care Workers' Depressive Symptoms, Burnout, and Absenteeism: A Randomized Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2023-11, Vol.80 (11), p.1101

2023

Volltextzugriff (PDF)

COMPARISON OF MONOENERGETIC PHOTON ORGAN DOSE RATE COEFFICIENTS FOR STYLIZED AND VOXEL PHANTOMS SUBMERGED IN AIR

Radiation protection dosimetry, 2016-12, Vol.172 (4), p.367-374

2016

Volltextzugriff (PDF)

Effective dose rate coefficients for exposure to contaminated soil

Radiation and environmental biophysics, 2017-08, Vol.56 (3), p.255-267

2017

Volltextzugriff (PDF)

Validation and uncertainty quantification of detector response functions for a 1″×2″ NaI collimated detector intended for inverse radioisotope source mapping applications

Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms, 2017-11, Vol.410 (C), p.1-15

2017

Volltextzugriff (PDF)

Pragmatic Implementation of a Music Intervention in Nursing Homes Before and During COVID-19

Journal of the American Medical Directors Association, 2024-02, Vol.25 (2), p.314-320

2024

Volltextzugriff (PDF)

Effective Dose Rate Coefficients for Immersions in Radioactive Air and Water

Radiation protection dosimetry, 2017-04, Vol.174 (2), p.275-286

2017

Volltextzugriff (PDF)

Estimated dose rates to members of the public from external exposure to patients with {sup 131}I thyroid treatment

Medical physics (Lancaster), 2015-04, Vol.42 (4)

2015

Volltextzugriff (PDF)

Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment

Medical physics (Lancaster), 2015-04, Vol.42 (4), p.1851-1857

2015

Volltextzugriff (PDF)

EFFECTIVE DOSE RATE COEFFICIENTS FOR IMMERSIONS IN RADIOACTIVE AIR AND WATER

Radiation protection dosimetry, 2018-10, Vol.181 (2), p.179-179

2018

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Humans
(17)
Life Sciences & Biomedicine
(17)
Adult
(7)
Female
(6)
Male
(6)
Oncology
(6)
Aged
(5)
Middle Aged
(5)
Environmental Sciences
(4)
Environmental Sciences & Ecology
(4)
Nuclear Science & Technology
(4)
Phantoms, Imaging
(4)
Photons
(4)
Radiology, Nuclear Medicine & Medical Imaging
(4)
Technology
(4)
Adolescent
(3)
Base Sequence
(3)
Biological And Medical Sciences
(3)
Disease-Free Survival
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

Decomposing inversion sets of permutations and applications to faces of the Littlewood–Richardson cone

Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn?

Bond strength of Bis-GMA and glass ionomer pit and fissure sealants using cyclic fatigue

Back to basics: tackling the challenges to bedside teaching

First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM)

A phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM)

196 A phase III randomised study of amifostine vs G-CSF to prevent the myelotoxicity of carboplatin chemotherapy in non-small cell lung cancer (NSCLC)

Docetaxel (D) in combination with amifostine (A) in metastatic breast cancer (MBC): A feasibility and pharmacoklnetlc study of the EORTC-investigational drug branch for breast cancer (IDBBC)

Phase I study on 4-weekly 6 hour infusion of BMY-25067 in patients (PTS) with solid tumors

Phase I study of the mitomycin C analogue BMY 25067

Validation of gamma-ray detection techniques for safeguards monitoring at natural uranium conversion facilities

G446(P) A systematic review evaluating the methodological quality of infant formula trials

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation

Effects of 12 Weeks of At-Home, Application-Based Exercise on Health Care Workers' Depressive Symptoms, Burnout, and Absenteeism: A Randomized Clinical Trial

COMPARISON OF MONOENERGETIC PHOTON ORGAN DOSE RATE COEFFICIENTS FOR STYLIZED AND VOXEL PHANTOMS SUBMERGED IN AIR

Effective dose rate coefficients for exposure to contaminated soil

Validation and uncertainty quantification of detector response functions for a 1″×2″ NaI collimated detector intended for inverse radioisotope source mapping applications

Pragmatic Implementation of a Music Intervention in Nursing Homes Before and During COVID-19

Effective Dose Rate Coefficients for Immersions in Radioactive Air and Water

Estimated dose rates to members of the public from external exposure to patients with {sup 131}I thyroid treatment

Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment

EFFECTIVE DOSE RATE COEFFICIENTS FOR IMMERSIONS IN RADIOACTIVE AIR AND WATER

Suchergebnisse filtern